A prospective cohort study of 103 patients in China finds that comorbid headache does not change short-term seizure-free ...
YPSILANTI, MI - An Ypsilanti teen who has spent years battling unpredictable seizures and fainting spells is raising money for a service dog. Abigail, 15, and her parents, Brian and Jennifer Ladd of ...
Positive trial data for Rapport’s lead pipeline candidate, RAP-219, a treatment for bipolar mania, points to a potential $1 ...
From a neurological perspective, understanding the different ways seizures present is essential for timely recognition, ...
Rapport Therapeutics reported that RAP-219 achieved statistically significant primary and secondary endpoints in a Phase 2 ...
A groundbreaking medical device that stimulates the brain without opening the skull offers new hope to epilepsy patients who ...
The latest valuation work on Rapport Therapeutics lifts estimated fair value from US$62.88 to US$69.06, putting a sharper ...
The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in the YMRS total score ...
Cadence Neuroscience, a clinical-stage company developing a biomarker-guided platform for personalized neuromodulation, ...
A new study from France and Sweden has found a link between epilepsy and dementia developing before age 65, with one specific group facing a sixfold higher risk. However, the actual number of people ...
CORE-VNS is the largest prospective, multinational observational study evaluating contemporary VNS Therapy devices in people with Drug-Resistant Epilepsy – Demonstrated 76% median reduction in seizure ...
A Japanese case report describes a woman with drug-resistant epilepsy whose seizures fell by about 60 percent after deep brain stimulation of only one side of the thalamus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results